Parents like Christine Smith Olsey faced a tough time when they tried to get help for their kids with disabilities. Olsey's son was struggling in school, and she knew something wasn't right. She asked for extra help, but the school didn't listen. So, she filed a complaint with the state and then wit
A Senate panel has sent Linda McMahon's nomination for Education secretary to the full Senate for a vote. This move comes despite concerns about President Trump's past remarks about shutting down the Education Department. McMahon, who co-founded and led the WWE with her husband Vince, is known for
In the world of medicine, especially in neurology, it's crucial to understand how doctors and trainees feel about their work environment. A recent study focused on this, looking at how different ways of showing appreciation are seen by faculty and trainees in a neurology department at a big academic
Lung cancer is a tricky disease, and one type, non-small cell lung cancer (NSCLC), can be even trickier. Why? Because it can have different mutations, and these mutations can affect how well treatments work. Two of these mutations are called KRAS G12C and KRAS G12D. They are not the same and can beh
Migraines are a big deal, affecting around 14. 4% of people worldwide. This means nearly one in seven individuals is dealing with this painful condition. The goal was to understand who gets migraines and how it impacts their healthcare needs. First, let's talk about the numbers. Migraines are more
Palantir, a software giant, is making waves in the artificial intelligence (AI) market. Loop Capital, a financial firm, has given it a thumbs-up with a buy rating and a price target of $141. This means they think the stock could jump by more than 25% from its current price. The firm believes Palanti
Alzheimer's disease is a tough opponent, but scientists are finding new ways to fight it. Gold nanoparticles, tiny particles made of gold, are proving to be a powerful tool in the battle against this neurodegenerative disease. These nanoparticles can be loaded with afzelin, a natural compound found
People with rheumatic diseases often take rituximab, a medicine that can make them more likely to catch COVID-19. Doctors wanted to see if a new treatment, tixagevimab-cilgavimab, could help. This combo was tested on patients already taking rituximab. The goal was to find out if it could stop COVID-
In February 2025, former President Donald Trump took the stage at the FII PRIORITY Summit in Miami Beach. This event, backed by Saudi government entities, was all about bringing together big names in business and politics. The main sponsor? The Saudi Public Investment Fund, with other Saudi governme
People with mental health issues have sometimes been linked to violent acts and other crimes. This has led to questions about how well community treatment orders (CTOs) work in managing these behaviors. CTOs are legal orders that require individuals to receive treatment in the community rather than
